Peiyuan Hao
About
In The Last Decade
Peiyuan Hao
17 papers receiving 702 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 569
- Cancer Research 471
- Cardiology and Cardiovascular Medicine 79
- Epidemiology 55
- Pathology and Forensic Medicine 50
Countries citing papers authored by Peiyuan Hao
This map shows the geographic impact of Peiyuan Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyuan Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyuan Hao more than expected).
Fields of papers citing papers by Peiyuan Hao
This network shows the impact of papers produced by Peiyuan Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyuan Hao. The network helps show where Peiyuan Hao may publish in the future.
Co-authorship network of co-authors of Peiyuan Hao
This figure shows the co-authorship network connecting the top 25 collaborators of Peiyuan Hao. A scholar is included among the top collaborators of Peiyuan Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiyuan Hao. Peiyuan Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 14 | |
| 4 | 71 | |
| 5 | 6 | |
| 6 | 14 | |
| 7 | 214 | |
| 8 | 35 | |
| 9 | 192 | |
| 10 | 3 | |
| 11 | 64 | |
| 12 | 3 | |
| 13 | Safety and efficacy of rivaroxaban versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a meta-analysis of observational studies. | 5 |
| 14 | 18 | |
| 15 | 10 | |
| 16 | 20 | |
| 17 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.